His and her health he donated one million dollars to the newly elected president Donald Trump’with inaugural fundconfirmed to CNBC on Tuesday.
The company, which offers a range of direct-to-consumer treatments for conditions such as weight loss, erectile dysfunction and hair loss, is the latest in a string of tech companies to try to ingratiate themselves with the new administration. OpenAI CEO Sam Altman and Target both announced Donations of one million dollars to the inaugural fund at the end of last year, i Amazon and Apple CEO Tim Cook also reportedly contributed.
“At Hims & Hers, we stand with leaders and advocates who are committed to improving America’s broken health care system,” the company said in a statement to CNBC.
Axios was the first to report on the Hims & Hers donation.
Hims & Hers was a breakout star in the digital health sector last year, largely due to the success of its popular new weight loss offering.
The company started prescribing drugs complex semaglutide through its platform in May after launching a weight loss program in late 2023. Semaglutide is the active ingredient in the Novo Nordiskthe successful drugs Ozempic and Wegovy, which can cost about $1,000 a month without insurance. Compounded semaglutide is a cheaper, customized alternative to brand-name drugs and can be manufactured when known drugs are available lack.
The future of compound GLP-1s in the US is not entirely clear, especially as members of Trump’s inner circle have expressed mixed opinions about the drugs more broadly. Robert F. Kennedy Jr.Trump’s choice to head the Department of Health and Human Services criticized GLP-1. He said CNBC in an interview that the “first line of response” to obesity should be lifestyle changes, although he added that “GLP drugs have their place.”
dr. Marty Makary, Trump’s pick to lead the Food and Drug Administration, worked as CEO of the telehealth company Sesame, which connects consumers with doctors who can prescribe GLP-1 compounds. However, Makary’s role on Sesame has been largely ceremonial in recent years.
Elon Muskthe Tesla The CEO, who has been a close confidante of Trump since the election, has openly voiced his support for the drugs.
“Nothing would do more to improve the health, lifespan and quality of life of Americans than making GLP inhibitors super cheap for the public,” Musk wrote in fast on its social media platform X in December.
At a press event in New York late last year attended by CNBC, Hims & Hers said it would work with the new management and share the company’s view on the value of medicine.
